Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1388651-30-6
2. E2609
3. E-2609
4. Elenbecestat [inn]
5. Elenbecestat [usan]
6. Rxj96xl94h
7. N-[3-[(4as,5r,7as)-2-amino-5-methyl-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-(difluoromethyl)pyrazine-2-carboxamide
8. 2-pyrazinecarboxamide, N-(3-((4as,5r,7as)-2-amino-5,7-dihydro-5-methyl-4h-furo(3,4-d)(1,3)thiazin-7a(4ah)-yl)-4-fluorophenyl)-5-(difluoromethyl)-
9. N-(3-((4as,5r,7as)-2-amino-5-methyl-4a,5-dihydro-4h-furo(3,4-d)(1,3)thiazin-7a(7h)-yl)-4-fluorophenyl)-5-(difluoromethyl)pyrazine-2-carboxamide
10. Elenbecestat; E2609
11. Elenbecestat (jan/usan)
12. Elenbecestat [jan]
13. Elenbecestat [usan:inn]
14. Unii-rxj96xl94h
15. Emapalumab [who-dd]
16. Elenbecestat [who-dd]
17. Gtpl9818
18. Schembl2620149
19. Chembl4204869
20. Ex-a3151
21. Bdbm50510823
22. S8600
23. Db15391
24. Ac-36887
25. Hy-109055
26. Cs-0031645
27. E2609e2609
28. D11509
29. D87146
30. E 2609
| Molecular Weight | 437.4 g/mol |
|---|---|
| Molecular Formula | C19H18F3N5O2S |
| XLogP3 | 1.4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 4 |
| Exact Mass | 437.11333049 g/mol |
| Monoisotopic Mass | 437.11333049 g/mol |
| Topological Polar Surface Area | 128 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 687 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Elenbecestat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elenbecestat, including repackagers and relabelers. The FDA regulates Elenbecestat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elenbecestat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Elenbecestat supplier is an individual or a company that provides Elenbecestat active pharmaceutical ingredient (API) or Elenbecestat finished formulations upon request. The Elenbecestat suppliers may include Elenbecestat API manufacturers, exporters, distributors and traders.
Elenbecestat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elenbecestat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elenbecestat GMP manufacturer or Elenbecestat GMP API supplier for your needs.
A Elenbecestat CoA (Certificate of Analysis) is a formal document that attests to Elenbecestat's compliance with Elenbecestat specifications and serves as a tool for batch-level quality control.
Elenbecestat CoA mostly includes findings from lab analyses of a specific batch. For each Elenbecestat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elenbecestat may be tested according to a variety of international standards, such as European Pharmacopoeia (Elenbecestat EP), Elenbecestat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elenbecestat USP).
LOOKING FOR A SUPPLIER?
